You are here

NeonMind Biosciences Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
NEON
CSE Index: 
Currency: 

The Issuer is engaged in preclinical research to develop potential clinical treatments and wellness products to address obesity and weight management conditions and to promote health and wellness. The Issuer operates three divisions: (i) a pharmaceutical division engaged in drug development of psychedelic compounds with two lead psilocybin-based drug candidates targeting obesity; and (ii) a medical services division focused on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings. 

You are here

NeonMind Biosciences Inc. (NEON)

SEDAR Information

Company Info

Address
Suite 200 - 1238 Homer St
Vancouver, BC V6B2Y5
Canada
Phone
1 866-811-8960
Email
info@neonmind.com
Website
http://www.neonmind.com
Listing date
Tuesday, December 29, 2020
Transfer Agent
Endeavor Trust Corporation
Auditor
Saturna Group Chartered Professional Accountants LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
128,275,430
Reserved for Issuance: 
157,221,500

Bulletins

29/12/2020

2020-1238 - New Listing - Neonmind Biosciences Inc. (NEON)

Le 29 decembre/December 2020

The common shares of Neonmind Biosciences Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

The Issuer is conducting research into potentially therapeutic uses of compounds found in psychedelic mushrooms and is commercializing edible mushroom infused beverages. 

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-01-25-Jamaica-Stock-Exchange-Conference_Website.png

17th Regional Investments & Capital Markets Conference 2022

Tuesday, January 25, 2022 to Thursday, January 27, 2022
VRIC_1200x675.jpg

Vancouver Resource Investment Conference (VRIC)

Tuesday, May 17, 2022 - 8:30am to Wednesday, May 18, 2022 - 5:30pm